Utah EVALI case series describes patient characteristics and vaping practices

An observational case series described 83 Utah residents with confirmed or probable e-cigarette, or vaping, product use-associated lung injury (EVALI). The study focused on characterizing patient demographics and their e-cigarette use practices. No primary or secondary clinical outcomes were reported, and no comparator group was included. The study did not report safety or tolerability data, including adverse events, serious adverse events, or discontinuations. Key limitations include the absence of reported outcomes, lack of a control group, and the descriptive nature of the analysis which precludes causal inference. The practice relevance of this report is limited to providing a descriptive profile of EVALI cases in one state; it does not offer evidence for clinical management or establish risk factors.